查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402032

到 2030 年局部麻醉市場預測：按類型、給藥途徑、最終用戶和地區進行的全球分析

Local Anesthesia Market Forecasts to 2030 - Global Analysis By Type, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球局部麻醉市場規模為 30 億美元，預計在預測期內將以 8.4% 的複合年成長率成長，到 2030 年達到 53 億美元。

局部麻醉是一種用於暫時麻木身體某些部位以緩解不適的醫療程序。將利多卡因或奴佛卡因等麻醉劑直接注射到患處，以阻斷神經訊號並停止疼痛感。在接受牙科治療、皮膚手術、關節注射等治療時，患者可以保持清醒和意識，不像全身麻醉會讓患者失去意識。

根據美國整形外科醫師協會統計，2020年美國進行了230萬例整容手術、1,320萬例美容微創手術和680萬例重組手術，比2019年增加了3%。

外科手術不斷增加

局部麻醉劑擴大用於各種外科手術，因為它們可以緩解某些不適而不使患者失去知覺。由於整形外科、牙科和皮膚科等許多醫學專業對外科手術的需求不斷增加，有效的疼痛管理是必要的。此外，門診治療和外科手術的日益普及也推動了對局部麻醉劑的需求。

缺乏熟練勞動力

局部麻醉在各種醫療手術中發揮重要作用，局部麻醉劑的給藥需要專業知識和訓練。然而，缺乏熟練的專業人員，例如麻醉師和護士，他們擁有安全有效實施局部麻醉所需的專業知識。這種短缺限制了局部麻醉服務的可用性，導致手術延誤和患者疼痛控制不足，並且是市場擴張的主要障礙。

技術開發

自動化藥物輸送和監測系統的開發可以幫助準確管理藥物給藥、提高病人安全並減輕醫療保健提供者的負擔。藥物基因組學、奈米技術和自動麻醉技術等技術發展擴大應用於各種外科手術。此外，該產業採用創新解決方案不僅會提高局部麻醉劑的有效性，還會推動市場擴張。

與副作用和過敏反應相關的風險

局部麻醉劑會引起過敏，並對敏感族群產生副作用。這包括呼吸困難、臉部和喉嚨腫脹以及低血壓等症狀。在極少數情況下，局部麻醉可能會導致暫時性或永久性神經損傷，從而導致麻木或癱瘓。此外，這些副作用和過敏反應會增加患者和醫療保健提供者的焦慮，並影響局部麻醉劑的需求和使用。

COVID-19 的影響

COVID-19大流行導致手術延遲、選擇性治療中斷以及醫療保健優先事項發生變化，對局部麻醉市場產生了負面影響。由於封鎖和安全問題導致非緊急醫療干預措施急劇下降，影響了局部麻醉劑的需求。其他導致市場下滑的因素包括患者偏好的變化、醫療資源有限和經濟狀況不確定。

預計製藥領域在預測期內將是最大的

由於緩釋性製劑（包括外用製劑、注射劑和經皮吸收貼片）的開發，預計製藥領域將佔據最大佔有率。持續研究和配方創新的目標是延長麻醉時間、減少副作用並改善患者的整體體驗。因此，全世界進行的醫療和牙科手術數量不斷增加，增加了對各種有效局部麻醉劑製劑的需求。

預計硬脊膜外麻醉領域在預測期內複合年成長率最高

預計硬膜外麻醉領域在預測期內將出現良好的成長。硬膜外麻醉常用於緩解分娩、手術和其他醫療過程中的不適。導管設計、影像技術和藥物配方的不斷發展正在促進硬膜外麻醉的改進。持續開發的目標是使硬膜外麻醉技術更安全、更準確。因此，這些因素正在顯著推動市場擴張。

佔有率最大的地區

由於中國、印度和日本等國家在麻醉劑輸送系統、配方和給藥方法方面取得了前沿進步，亞太地區在預測期內獲得了最大的市場佔有率。電腦輔助麻醉劑給藥和超音波引導手術就是例子，它們提供了準確性、安全性和病人舒適度。因此，越來越多的醫療設施和高素質醫療保健專業人員，加上該地區致力於實施尖端醫療技術，正在推動市場擴張。

複合年成長率最高的地區：

由於先進的醫療基礎設施和完善的醫療保健系統，預計北美在預測期內將出現盈利成長。先進的麻醉輸送系統和監測設備等技術進步體現了該地區對尖端醫療保健的承諾。此外，該地區的監管環境受到美國FDA 和加拿大衛生署等機構制定的嚴格標準的監管，確保了高品質和安全的實踐，從而推動了市場擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球局部麻醉市場：依類型

  • 公式
    • 注射液
    • 局部乳霜和軟膏
    • 噴
    • 修補
    • 滴劑和凝膠
  • 運輸方式
    • 吸入
    • 注射
    • 靜脈 (IV)局部麻醉
    • 口服含片和漱口水
  • 其他類型

第6章全球局部麻醉市場：依給藥途徑

  • 浸潤
  • 硬脊膜外麻醉
  • 膀胱內（膀胱）途徑
  • 鼻內途徑
  • 關節內 (IA) 路線
  • 骨內途徑
  • 經皮途徑
    • 共晶片
    • 離子電滲透療法
    • 磁泳
  • 鄰裡
  • 其他給藥途徑

第7章全球局部麻醉市場：依最終使用者分類

  • 牙醫診所
  • 門診手術中心
  • 醫院和診所
  • 其他最終用戶

第8章全球局部麻醉市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • 3M
  • Pfizer Inc.
  • Mylan
  • Molteno
  • B. Braun Melsungen AG
  • Septodont
  • AstraZeneca
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals
  • Dentsply Sirona
  • Teva Pharmaceutical Industries
  • Piramal Enterprises
Product Code: SMRC24552

According to Stratistics MRC, the Global Local Anesthesia Market is accounted for $3.0 billion in 2023 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Local anesthesia is a medical treatment used to temporarily numb a specific area of the body to eliminate discomfort. It entails injecting anesthetics, such as lidocaine or novocaine, directly into the affected area to block nerve signals and stop pain perception. When receiving dental work, skin surgery, or joint injections, patients can stay awake and conscious, unlike with general anesthesia, which causes unconsciousness.

According to the American Society of Plastic Surgeons, in 2020, 2.3 million cosmetic surgical procedures, 13.2 million cosmetic minimally invasive procedures, and 6.8 million reconstructive procedures were performed in the United States 2020, representing a 3% increase over 2019.

Market Dynamics:

Driver:

Rising surgical procedures

Local anesthetics are becoming more and more used in a variety of surgical procedures because they can relieve specific discomfort without knocking patients out. Effective pain management is necessary due to the growing need for surgical procedures in a number of medical specialties, such as orthopaedics, dentistry, and dermatology. Additionally, the increasing prevalence of outpatient treatments and surgical improvements is driving up demand for local anesthetics.

Restraint:

Lack of skilled workforce

Local anesthesia plays a vital role in various medical procedures, administering local anesthetics requires specialized knowledge and training. However, there is a shortage of skilled professionals, such as anaesthesiologists or nurse anesthetists, who possess the necessary expertise in administering local anesthesia safely and effectively. This scarcity limits the availability of local anesthesia services, leading to delays in procedures or inadequate pain management for patients which significantly hamper market expansion.

Opportunity:

Technological developments

The development of automated systems for anesthesia delivery and monitoring helps in maintaining precise control over drug administration, improving patient safety, and reducing the workload on healthcare providers. Technological developments like pharmacogenomics, nanotechnology and automated anesthesia techniques are increasingly being employed for various surgical procedures. Furthermore, as the industry adopts innovative solutions, not only enhances the efficacy of local anesthetics but also propels market expansion.

Threat:

Risks associated with side effects and allergic reactions

The local anesthetics may develop allergy, which could result adverse reactions in sensitive individuals. This can include symptoms such as difficulty breathing, swelling of the face or throat, and a drop in blood pressure. In rare cases, local anesthesia may cause temporary or, very rarely, permanent nerve damage causing tingling and numbness. Furthermore, these side effects and allergic reactions can raise the anxiety of patients and healthcare providers, which may impact the demand for and uptake of local anesthetics.

COVID-19 Impact

The COVID-19 pandemic had a detrimental effect on the local anesthesia market as it caused delays in surgeries, disruptions in elective treatments, and a change in healthcare priorities. The need for local anesthetics was impacted by a sharp decline in non-urgent medical interventions brought on by lockdowns and safety concerns. Additional factors contributing to a slowdown included changing patient preferences, limited healthcare resources, and uncertain economic conditions which gradually hamper the market size.

The formulations segment is expected to be the largest during the forecast period

The formulations segment is estimated to hold the largest share, due to the development of prolonged-release or extended-release formulations including topical, injectables, and transdermal patches. The goal of ongoing research and formulation innovation is to prolong anesthesia, lessen side effects, and enhance the overall patient experience. Therefore, the growing number of medical and dental operations performed worldwide is driving the need for a variety of efficient local anesthetic formulations.

The epidural segment is expected to have the highest CAGR during the forecast period

The epidural segment is anticipated to have lucrative growth during the forecast period. This approach is frequently employed to relieve discomfort during labor, surgery, and other medical operations. Continuous developments in catheter design, imaging techniques, and drug formulations contribute to the refinement of epidural anesthesia. The goal of ongoing developments is to make epidural anesthetic techniques safer and more accurate. Thus, these factors significantly drive market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to cutting-edge advancements in anesthetic delivery systems, formulations, and administration methods in nations like China, India, and Japan. Computer-assisted anesthetic delivery and ultrasound-guided surgeries are some of the examples included, which provide accuracy, safety, and patient comfort. Therefore, an increasing number of medical facilities and highly qualified healthcare workers, coupled with the region's dedication to implementing cutting-edge medical technologies which propels market expansion.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to advanced healthcare infrastructure and a well-established medical system. Technological advancements, including sophisticated anesthesia delivery systems and monitoring devices, characterize the region's commitment to cutting-edge healthcare practices. Additionally, the region's regulatory landscape, governed by stringent standards set by entities like the U.S. FDA and Health Canada, ensures high-quality and safe practices which are boosting market expansion.

Key players in the market:

Some of the key players in the Local Anesthesia Market include 3M, Pfizer Inc., Mylan, Molteno, B. Braun Melsungen AG, Septodont, AstraZeneca, Fresenius SE & Co. KGaA , Hikma Pharmaceuticals, Dentsply Sirona, Teva Pharmaceutical Industries and Piramal Enterprises.

Key Developments:

In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A.

In July 2023, Flagship Pioneering, Inc. and Pfizer Inc. announced the companies have partnered to create a new pipeline of innovative medicines.

In July 2023, 3M Health Information Systems (HIS) announced that U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications software.

Types Covered:

  • Formulations
  • Delivery Methods
  • Other Types

Route of Administrations Covered:

  • Infiltration
  • Epidural
  • Intravesical (Bladder) Route
  • Intranasal Route
  • Intra-Articular (IA) Route
  • Intra-Osseous Route
  • Transdermal Route
  • Peripheral
  • Other Route of Administrations

End Users Covered:

  • Dental Clinics
  • Ambulatory Surgical Centers
  • Hospitals and Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Local Anesthesia Market, By Type

  • 5.1 Introduction
  • 5.2 Formulations
    • 5.2.1 Injectable Solutions
    • 5.2.2 Topical Creams and Ointments
    • 5.2.3 Sprays
    • 5.2.4 Patches
    • 5.2.5 Drops and Gels
  • 5.3 Delivery Methods
    • 5.3.1 Inhalation
    • 5.3.2 Injections
    • 5.3.3 Intravenous (IV) Regional Anesthesia
    • 5.3.4 Oral Lozenges and Gargles
  • 5.4 Other Types

6 Global Local Anesthesia Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Infiltration
  • 6.3 Epidural
  • 6.4 Intravesical (Bladder) Route
  • 6.5 Intranasal Route
  • 6.6 Intra-Articular (IA) Route
  • 6.7 Intra-Osseous Route
  • 6.8 Transdermal Route
    • 6.8.1 Eutectic Patches
    • 6.8.2 Iontophoresis
    • 6.8.3 Magnetophoresis
  • 6.9 Peripheral
  • 6.10 Other Route of Administrations

7 Global Local Anesthesia Market, By End User

  • 7.1 Introduction
  • 7.2 Dental Clinics
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Hospitals and Clinics
  • 7.4 Other End Users

8 Global Local Anesthesia Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M
  • 10.2 Pfizer Inc.
  • 10.3 Mylan
  • 10.4 Molteno
  • 10.5 B. Braun Melsungen AG
  • 10.6 Septodont
  • 10.7 AstraZeneca
  • 10.8 Fresenius SE & Co. KGaA
  • 10.9 Hikma Pharmaceuticals
  • 10.10 Dentsply Sirona
  • 10.11 Teva Pharmaceutical Industries
  • 10.12 Piramal Enterprises

List of Tables

  • Table 1 Global Local Anesthesia Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Local Anesthesia Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Local Anesthesia Market Outlook, By Formulations (2021-2030) ($MN)
  • Table 4 Global Local Anesthesia Market Outlook, By Injectable Solutions (2021-2030) ($MN)
  • Table 5 Global Local Anesthesia Market Outlook, By Topical Creams and Ointments (2021-2030) ($MN)
  • Table 6 Global Local Anesthesia Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 7 Global Local Anesthesia Market Outlook, By Patches (2021-2030) ($MN)
  • Table 8 Global Local Anesthesia Market Outlook, By Drops and Gels (2021-2030) ($MN)
  • Table 9 Global Local Anesthesia Market Outlook, By Delivery Methods (2021-2030) ($MN)
  • Table 10 Global Local Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 11 Global Local Anesthesia Market Outlook, By Injections (2021-2030) ($MN)
  • Table 12 Global Local Anesthesia Market Outlook, By Intravenous (IV) Regional Anesthesia (2021-2030) ($MN)
  • Table 13 Global Local Anesthesia Market Outlook, By Oral Lozenges and Gargles (2021-2030) ($MN)
  • Table 14 Global Local Anesthesia Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 15 Global Local Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 16 Global Local Anesthesia Market Outlook, By Infiltration (2021-2030) ($MN)
  • Table 17 Global Local Anesthesia Market Outlook, By Epidural (2021-2030) ($MN)
  • Table 18 Global Local Anesthesia Market Outlook, By Intravesical (Bladder) Route (2021-2030) ($MN)
  • Table 19 Global Local Anesthesia Market Outlook, By Intranasal Route (2021-2030) ($MN)
  • Table 20 Global Local Anesthesia Market Outlook, By Intra-Articular (IA) Route (2021-2030) ($MN)
  • Table 21 Global Local Anesthesia Market Outlook, By Intra-Osseous Route (2021-2030) ($MN)
  • Table 22 Global Local Anesthesia Market Outlook, By Transdermal Route (2021-2030) ($MN)
  • Table 23 Global Local Anesthesia Market Outlook, By Eutectic Patches (2021-2030) ($MN)
  • Table 24 Global Local Anesthesia Market Outlook, By Iontophoresis (2021-2030) ($MN)
  • Table 25 Global Local Anesthesia Market Outlook, By Magnetophoresis (2021-2030) ($MN)
  • Table 26 Global Local Anesthesia Market Outlook, By Peripheral (2021-2030) ($MN)
  • Table 27 Global Local Anesthesia Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 28 Global Local Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Local Anesthesia Market Outlook, By Dental Clinics (2021-2030) ($MN)
  • Table 30 Global Local Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 31 Global Local Anesthesia Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 32 Global Local Anesthesia Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.